Hologic, Inc.’s HOLX GYN Surgical business is likely to have witnessed strong performance — owing to MyoSure and NovaSure — and increasing contributions from the company’s laparoscopic portfolio of ...

Hologic, Inc. HOLX GYN Surgical is expected to have registered vital contributions from MyoSure and the Related fluid system, with an increasing contribution from its laparoscopic portfolio. Moreover, ...

The global Gynecological Devices market is expanding, supported by the higher prevalence of diseases like PCOS, uterine fibroids and cervical cancer, continued innovation in minimally invasive ...

Hologic (HOLX) has strengthened its GYN surgical segment with the acquisition of privately-held Massachusetts-based Interlace Medical for $125 million in cash and two annual contingent payments, ...

With Hologic, Inc. HOLX gearing up to release its fiscal 2025 first-quarter financial results on Feb. 5 after the market closes, the company’s Breast Health segment is expected to have benefited from ...

Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...